Making a case for del(1p) as a high‐risk abnormality in multiple myeloma 🔗 Access full article via ACS Cancer Cancer, Volume 129, Issue 16, Page 2450-2452, Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
